Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10497 - 10504 of 11439 results
Rx for HIPAA Compliance
May 17, 2013| Blog| Viewpoint
IRS, Treasury Department Issue Proposed Rules Governing Minimum Value, Affordability, and Wellness Programs
May 16, 2013| Advisory| Viewpoint
New York City Passes Earned Sick Time Act; Expects to Override Mayor Bloomberg's Threatened Veto Yet Again
May 15, 2013| Blog| Viewpoint
July 1 COPPA Compliance Deadline is Approaching
May 15, 2013| Blog| Viewpoint
Five Years in the Making - IRS Releases Findings from Colleges and Universities Compliance Project
May 13, 2013| Blog| Viewpoint
Five Takeaways from the OIG’s Special Advisory Bulletin on Exclusion
May 10, 2013| Advisory| Viewpoint
How to Minimize FCPA Risk in Health Care Acquisitions
May 10, 2013| Blog| Viewpoint
Final Medical Marijuana Regulations Approved in Massachusetts
May 10, 2013| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.